FDA Adverse Event Other Summary report: N

ADVIA CENTAUR CP ESTRADIOL-6 III ASSAY

MDR report key: 1610916 · Received February 16, 2010

Report

Report Number
1219913-2010-00019
Event Type
Other
Date Received
February 16, 2010
Date of Event
January 28, 2010
Report Date
February 1, 2010
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS INC.
Product Code
CHP
PMA / PMN Number
EXEMPT
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
VA, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

A SIEMENS FIELD SERVICE ENGINEER (FSE) WAS SENT TO THE CUSTOMER SITE. ANALYSIS OF THE INSTRUMENT AND INSTRUMENT DATA INDICATE THAT THE CAUSE FOR THE DISCORDANT ESTRADIOL-6 III RESULT IS UNK. THE INSTRUMENT IS PERFORMING WITHIN SPECIFICATIONS. NO FURTHER EVALUATION OF THE DEVICE IS REQUIRED.

Description of Event or Problem · 1

DISCORDANT ADVIA CENTAUR CP ESTRADIOL-6 III ASSAY RESULTS WERE OBTAINED ON A PT SAMPLE. THE NEAT RESULTS FOR ESTRADIOL-6 III DID NOT MATCH THE 1:5 DILUTED RESULTS. PT TREATMENT WAS NOT PRESCRIBED OR ALTERED. THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT ESTRADIOL-6 III RESULTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ADVIA CENTAUR CP ESTRADIOL-6 III ASSAY E2-6 III IMMUNOASSAY CHP SIEMENS HEALTHCARE DIAGNOSTICS INC. NA 131

Patients

Seq Age Sex Outcome Treatment
1 36 YR